Germany’s BioNTech has scaled up its projections for the number of doses of its Covid-19 vaccine it will make this year from 1.3 billion to 2 billion, as it seeks...
French pharma Sanofi is once again boosting its immunotherapy capabilities, this time with the acquisition of UK biotech Kymab. The company will make an upfront payment...
Finland’s Neste has taken a minority stake in Alterra Energy as the two collaborate to develop and license the US company’s chemical recycling technology. The size of the...
German pharmaceuticals, chemicals and life sciences group Merck has acquired compatriot CDMO AmpTec for an undisclosed sum. The deal is designed to strengthen its life...
The UK’s Medicines and Healthcare Products Regulatory Agency (MRHA) cleared US biotech Moderna’s mRNA-based Covid-19 vaccine for emergency use on Jan. 7, bringing the...
DuPont has started a share exchange offer as part of a Reverse Morris Trust transaction that will see it merge its Nutrition & Biosciences (N&B) business into...
As it rolls out an increasing number of doses of its mRNA-based Covid-19 vaccine, US biotech Moderna has appointed a pharma industry veteran to spearhead the effort...
In “normal” times, with the exception of live vaccine manufacturers, control of viruses in cleanrooms is not usually the highest priority within contamination control.
In its first deal of 2021, Azelis has purchased a majority shareholding in Vietnamese companies MKVN Chemicals and Viet Chemicals Trading and Service through their parent...
